Literature DB >> 3796196

Influence of an extract of Ginkgo biloba on cerebral blood flow and metabolism.

J Krieglstein, T Beck, A Seibert.   

Abstract

The purpose of the present investigation was to examine the effects of an extract of Ginkgo biloba (EGB) on blood glucose levels, on local cerebral blood flow as well as on cerebral glucose concentration and consumption. The local cerebral blood flow (LCBF) was measured in conscious rats by means of the 14C-iodoantipyrine technique and local cerebral glucose utilization (LCGU) by 14C-2-deoxy-glucose autoradiography. EGB increased the LCBF in 39 analyzed, anatomically defined brain structures by 50 to 100 per cent. No influence of EGB on LCGU was demonstrable. However, EGB enhanced the blood glucose level dose-dependently. Substrates and metabolites of energy metabolism were measured in the cortex of the isolated rat brain perfused at constant rate and with 7 mmol/l glucose added to the perfusion medium. In these experiments EGB decreased the cortical glucose concentration without other substrate levels being changed. These results suggest that glucose uptake may be inhibited by EGB. It is argued that the effects of EGB on brain glucose concentration and blood flow may contribute to its protection of brain tissue against ischemic or hypoxic damage.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3796196     DOI: 10.1016/0024-3205(86)90663-6

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  14 in total

1.  The combined effects of ginkgo biloba extracts and aspirin on viability of sk-N-mc, neuroblastoma cell line in hypoxia and reperfusion condition.

Authors:  Sung-Hwan Moon; Yong-Jik Lee; Soo Yong Park; Kwan-Young Song; Min-Ho Kong; Jung-Hee Kim
Journal:  J Korean Neurosurg Soc       Date:  2011-01-31

2.  Intra-amygdaloid infusion of Ginkgo biloba leaf extract (EGb761) facilitates fear-potentiated startle in rats.

Authors:  Yi-Ling Yang; Chia-Wen Hsieh; Yu-Yuan P Wo; Yi-Chung Yang; Kwok-Tung Lu
Journal:  Psychopharmacology (Berl)       Date:  2008-06-20       Impact factor: 4.530

3.  The role of the dorsal hippocampus on the Ginkgo biloba facilitation effect of fear extinction as assessed with fear-potentiated startle.

Authors:  Yu-Fang Shen; Yu-Hsuan Chou; Yi-Ling Yang; Kwok-Tung Lu
Journal:  Psychopharmacology (Berl)       Date:  2011-03-15       Impact factor: 4.530

4.  Differential cognitive effects of Ginkgo biloba after acute and chronic treatment in healthy young volunteers.

Authors:  Sarah Elsabagh; David E Hartley; Osama Ali; Elizabeth M Williamson; Sandra E File
Journal:  Psychopharmacology (Berl)       Date:  2005-03-01       Impact factor: 4.530

Review 5.  Ginkgo biloba for acute ischaemic stroke.

Authors:  X Zeng; M Liu; Y Yang; Y Li; K Asplund
Journal:  Cochrane Database Syst Rev       Date:  2005-10-19

6.  Impact of Ginkgo Biloba Extract EGb 761 on ischemia/reperfusion - induced oxidative stress products formation in rat forebrain.

Authors:  A Uríková; E Babusíková; D Dobrota; A Drgová; P Kaplán; Z Tatarková; J Lehotský
Journal:  Cell Mol Neurobiol       Date:  2006-04-14       Impact factor: 5.046

7.  Nutritional prevention on hypertension, cerebral hemodynamics and thrombosis in stroke-prone spontaneously hypertensive rats.

Authors:  Takanori Noguchi; Katsumi Ikeda; Yasuto Sasaki; Yukio Yamori
Journal:  Cell Mol Neurobiol       Date:  2004-10       Impact factor: 5.046

8.  Modifiable Midlife Risk Factors for Late-Life Cognitive Impairment and Dementia.

Authors:  Tiffany F Hughes; Mary Ganguli
Journal:  Curr Psychiatry Rev       Date:  2009-05-01

9.  Ginkgo biloba extract neuroprotective action is dependent on heme oxygenase 1 in ischemic reperfusion brain injury.

Authors:  Sofiyan Saleem; Hean Zhuang; Shyam Biswal; Yves Christen; Sylvain Doré
Journal:  Stroke       Date:  2008-10-09       Impact factor: 7.914

10.  Comparative Electropharmacological Actions of Some Constituents from Ginkgo biloba Extract in Guinea-pig Ventricular Cardiomyocytes.

Authors:  Hiroyasu Satoh
Journal:  Evid Based Complement Alternat Med       Date:  2004-10-27       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.